Andere talen Pacific Shuanglin Bio-pharmacy Co., LTD

Aandelen

000403

CNE000000F14

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
29,29 ^CNY	-1,61%		-1,94%	+7,53%

26/04	Pacific Shuanglin Bio-pharmacy Co, LTD rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
15/04	Pacific Shuanglin Bio-pharmacy's winst in 2023 stijgt met 4% ondanks lagere omzet; aandelen stijgen met 4%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4%	15/04
Pacific Shuanglin Bio-pharmacy's Profit Seen More Than Doubling in Q1; Shares Up 3%	15/04
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	12/04
Pacific Shuanglin Bio-pharmacy Co., LTD announced a financing transaction	23/02
Pacific Shuanglin Bio-pharmacy Unit Gets Nod to Trial Human Coagulation Factor IX	06/11
Pacific Shuanglin Bio-pharmacy Co., LTD Approves Board Appointments	26-10-23
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	18-10-23
Pacific Shuanglin Bio-pharmacy Obtains Another Blood Collection License	22-09-23
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23
Pacific Shuanglin Bio-pharmacy Obtains Blood Plasma Collection License	08-08-23
Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.	21-07-23
Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback announced on September 1, 2022 has expired with 1,968,378 shares, representing 0.27% for CNY 40.1 million.	20-07-23
Pacific Shuanglin Bio-Pharmacy Co., Ltd Announces Final Dividend Implementation on A Shares for the Year 2022, Payable on July 20, 2023	14-07-23
Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.	03-07-23
Pacific Shuanglin Bio-pharmacy's Unit Gets Permit to Operate Two Plasma Hubs	26-05-23
Pacific Shuanglin Bio-Pharmacy Co., Ltd Approves 2022 Profit Distribution Plan	23-05-23
Gongqingcheng Shengbang Yinghao Investment Partnership (Limited Partnership) completed the acquisition of 20.99% stake in Pacific Shuanglin Bio-pharmacy Co., LTD from Hangzhou Zhemintou Tianhong Investment Partnership Enterprise (LP) and Zhejiang Private Enterprise United Investment Co., Ltd.	23-05-23
Pacific Shuanglin Bio-pharmacy Registers Blood Clotting Drug	18-05-23
Pacific Shuanglin Bio-pharmacy Signs Drug Supply, Distribution Deal With Brazil’s Hypera Pharma	05-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pacific Shuanglin Bio-pharmacy Co., LTD

Aandelen

000403

CNE000000F14

Andere talen

Filters